

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 8.86739535 |
| 2 | negative thymic T cell selection (GO:0045060) | 8.70340859 |
| 3 | positive thymic T cell selection (GO:0045059) | 8.68484208 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 8.55532016 |
| 5 | thymic T cell selection (GO:0045061) | 8.10875635 |
| 6 | positive T cell selection (GO:0043368) | 7.91031762 |
| 7 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 7.87906162 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.64629945 |
| 9 | T cell selection (GO:0045058) | 7.52383875 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 6.80664810 |
| 11 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 6.60294465 |
| 12 | regulation of T cell tolerance induction (GO:0002664) | 6.46486120 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.43359560 |
| 14 | negative regulation of cell killing (GO:0031342) | 6.43359560 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.42032096 |
| 16 | response to interleukin-15 (GO:0070672) | 6.18025850 |
| 17 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.15630080 |
| 18 | leukocyte aggregation (GO:0070486) | 5.81357445 |
| 19 | T cell receptor signaling pathway (GO:0050852) | 5.71875563 |
| 20 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 5.71846021 |
| 21 | cellular response to interleukin-15 (GO:0071350) | 5.62908374 |
| 22 | T cell costimulation (GO:0031295) | 5.50439307 |
| 23 | lymphocyte costimulation (GO:0031294) | 5.41502529 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.41100376 |
| 25 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.41100376 |
| 26 | positive regulation of tolerance induction (GO:0002645) | 5.29504775 |
| 27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.10051918 |
| 28 | interferon-gamma production (GO:0032609) | 5.02967942 |
| 29 | T cell migration (GO:0072678) | 4.97306126 |
| 30 | regulation of regulatory T cell differentiation (GO:0045589) | 4.90239882 |
| 31 | positive regulation of interleukin-2 production (GO:0032743) | 4.80738401 |
| 32 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.80712190 |
| 33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.80267885 |
| 34 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.77303101 |
| 35 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.67648967 |
| 36 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.67648967 |
| 37 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.62451690 |
| 38 | regulation of tolerance induction (GO:0002643) | 4.60591052 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.49094380 |
| 40 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.41393738 |
| 41 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.41393738 |
| 42 | regulation of monocyte differentiation (GO:0045655) | 4.38766756 |
| 43 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.36117613 |
| 44 | tolerance induction (GO:0002507) | 4.31403082 |
| 45 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.20286469 |
| 46 | positive regulation of humoral immune response (GO:0002922) | 4.17116999 |
| 47 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.03913755 |
| 48 | mast cell activation (GO:0045576) | 3.98231179 |
| 49 | activated T cell proliferation (GO:0050798) | 3.92758205 |
| 50 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.87491003 |
| 51 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.86292650 |
| 52 | positive regulation of B cell mediated immunity (GO:0002714) | 3.86292650 |
| 53 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.81741427 |
| 54 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.77962800 |
| 55 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.75531296 |
| 56 | regulation of defense response to virus by virus (GO:0050690) | 3.73938366 |
| 57 | T cell differentiation (GO:0030217) | 3.71910321 |
| 58 | regulation of isotype switching (GO:0045191) | 3.64235686 |
| 59 | regulation of response to interferon-gamma (GO:0060330) | 3.61824321 |
| 60 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.61745000 |
| 61 | regulation of B cell mediated immunity (GO:0002712) | 3.61440814 |
| 62 | positive regulation of immune response to tumor cell (GO:0002839) | 3.60814746 |
| 63 | regulation of immune response to tumor cell (GO:0002837) | 3.60814746 |
| 64 | regulation of response to tumor cell (GO:0002834) | 3.60814746 |
| 65 | positive regulation of response to tumor cell (GO:0002836) | 3.60814746 |
| 66 | positive regulation of interleukin-4 production (GO:0032753) | 3.52739634 |
| 67 | T cell activation (GO:0042110) | 3.51237392 |
| 68 | positive regulation of isotype switching (GO:0045830) | 3.51017616 |
| 69 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.50501794 |
| 70 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.50399714 |
| 71 | regulation of interleukin-2 production (GO:0032663) | 3.46950850 |
| 72 | T cell homeostasis (GO:0043029) | 3.43383508 |
| 73 | negative regulation of T cell mediated immunity (GO:0002710) | 3.37818739 |
| 74 | response to type I interferon (GO:0034340) | 3.37347383 |
| 75 | positive regulation of cell killing (GO:0031343) | 3.32560697 |
| 76 | leukocyte cell-cell adhesion (GO:0007159) | 3.32159784 |
| 77 | regulation of interleukin-4 production (GO:0032673) | 3.31566314 |
| 78 | regulation of cell killing (GO:0031341) | 3.30983441 |
| 79 | natural killer cell differentiation (GO:0001779) | 3.30446372 |
| 80 | heterotypic cell-cell adhesion (GO:0034113) | 3.29592019 |
| 81 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.29541430 |
| 82 | type I interferon signaling pathway (GO:0060337) | 3.28519740 |
| 83 | cellular response to type I interferon (GO:0071357) | 3.28519740 |
| 84 | Peyers patch development (GO:0048541) | 3.25906465 |
| 85 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.25906465 |
| 86 | positive regulation of T cell activation (GO:0050870) | 3.25558385 |
| 87 | alpha-beta T cell differentiation (GO:0046632) | 3.24084841 |
| 88 | regulation of immunoglobulin production (GO:0002637) | 3.23913325 |
| 89 | natural killer cell activation (GO:0030101) | 3.22358837 |
| 90 | alpha-beta T cell activation (GO:0046631) | 3.21648767 |
| 91 | B cell mediated immunity (GO:0019724) | 3.21555023 |
| 92 | mast cell activation involved in immune response (GO:0002279) | 3.19956520 |
| 93 | mast cell degranulation (GO:0043303) | 3.19956520 |
| 94 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.17840382 |
| 95 | regulation of B cell differentiation (GO:0045577) | 3.11630402 |
| 96 | NIK/NF-kappaB signaling (GO:0038061) | 3.11615492 |
| 97 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.09100743 |
| 98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.08887982 |
| 99 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.07660525 |
| 100 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.00401668 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.63185483 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.80928636 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.07035398 |
| 4 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.96693049 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.92180155 |
| 6 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.88670772 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.87884482 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.83448781 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.81514100 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.74138930 |
| 11 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.63485619 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 3.39518877 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 3.32734424 |
| 14 | UTX_26944678_Chip-Seq_JUKART_Human | 3.04765621 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 3.02851433 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.88080402 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80624248 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57260187 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.53357235 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.34977523 |
| 21 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.28205389 |
| 22 | MAF_26560356_Chip-Seq_TH2_Human | 2.27275727 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.16509273 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15000904 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.11538422 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.08960472 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.05210417 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.04058686 |
| 29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85004068 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78396676 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.74606103 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74229597 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.73833714 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70616312 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.69619411 |
| 36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66067063 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.65182315 |
| 38 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.64822702 |
| 39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.64026648 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61657055 |
| 41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57701460 |
| 42 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53037740 |
| 43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.52639064 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.46101335 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.45825930 |
| 46 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43422367 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43025747 |
| 48 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41158152 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39433955 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36520358 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34576992 |
| 52 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.32595527 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30441930 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30083536 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26318666 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24234678 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21573961 |
| 58 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.16239700 |
| 59 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.12837244 |
| 60 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11698723 |
| 61 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07590246 |
| 62 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95589097 |
| 63 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94637721 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93697772 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92937482 |
| 66 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.92286303 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91553448 |
| 68 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89460593 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88585170 |
| 70 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.87373944 |
| 71 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.86765628 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85768527 |
| 73 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.85607585 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85515716 |
| 75 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83750372 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.83160783 |
| 77 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80570461 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78813010 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77732687 |
| 80 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.77550437 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76979645 |
| 82 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76950619 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73549665 |
| 84 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.69516401 |
| 85 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.68707292 |
| 86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.68236862 |
| 87 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.68219451 |
| 88 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.67878609 |
| 89 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.66525189 |
| 90 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.66386403 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65497443 |
| 92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.61775410 |
| 93 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.61072785 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61048081 |
| 95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.60422705 |
| 96 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.59496994 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.58864604 |
| 98 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.58742501 |
| 99 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.58412525 |
| 100 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.57664808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.12813140 |
| 2 | MP0005671_abnormal_response_to | 4.73794005 |
| 3 | MP0002166_altered_tumor_susceptibility | 3.77606196 |
| 4 | MP0000685_abnormal_immune_system | 3.60251725 |
| 5 | MP0003300_gastrointestinal_ulcer | 3.18782912 |
| 6 | MP0009333_abnormal_splenocyte_physiolog | 3.17800702 |
| 7 | MP0001835_abnormal_antigen_presentation | 3.12470530 |
| 8 | MP0001800_abnormal_humoral_immune | 3.11258785 |
| 9 | MP0009785_altered_susceptibility_to | 3.07419115 |
| 10 | MP0002006_tumorigenesis | 2.98197039 |
| 11 | MP0001790_abnormal_immune_system | 2.96497977 |
| 12 | MP0005387_immune_system_phenotype | 2.96497977 |
| 13 | MP0000703_abnormal_thymus_morphology | 2.88303352 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.85402034 |
| 15 | MP0002398_abnormal_bone_marrow | 2.83800478 |
| 16 | MP0003724_increased_susceptibility_to | 2.82235524 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.82209081 |
| 18 | MP0002723_abnormal_immune_serum | 2.82166891 |
| 19 | MP0001819_abnormal_immune_cell | 2.78549684 |
| 20 | MP0006082_CNS_inflammation | 2.76830580 |
| 21 | MP0005025_abnormal_response_to | 2.55893495 |
| 22 | MP0003866_abnormal_defecation | 2.54229731 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.48135291 |
| 24 | MP0004947_skin_inflammation | 2.45373709 |
| 25 | MP0000716_abnormal_immune_system | 2.44410388 |
| 26 | MP0002405_respiratory_system_inflammati | 2.43500244 |
| 27 | MP0002722_abnormal_immune_system | 2.40248669 |
| 28 | MP0010155_abnormal_intestine_physiology | 2.32552993 |
| 29 | MP0002396_abnormal_hematopoietic_system | 2.28086374 |
| 30 | MP0003436_decreased_susceptibility_to | 2.25933522 |
| 31 | MP0000689_abnormal_spleen_morphology | 2.23812757 |
| 32 | MP0002933_joint_inflammation | 2.08634697 |
| 33 | MP0002429_abnormal_blood_cell | 1.97545779 |
| 34 | MP0001873_stomach_inflammation | 1.96918759 |
| 35 | MP0003303_peritoneal_inflammation | 1.75686398 |
| 36 | MP0002419_abnormal_innate_immunity | 1.67170280 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.63083788 |
| 38 | MP0004510_myositis | 1.62248717 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.62099022 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.59092580 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.45990668 |
| 42 | MP0002009_preneoplasia | 1.42645775 |
| 43 | MP0004381_abnormal_hair_follicle | 1.40276199 |
| 44 | MP0000858_altered_metastatic_potential | 1.37915973 |
| 45 | MP0001853_heart_inflammation | 1.37632997 |
| 46 | MP0003448_altered_tumor_morphology | 1.36659133 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.27218258 |
| 48 | MP0000490_abnormal_crypts_of | 1.26505731 |
| 49 | MP0008469_abnormal_protein_level | 1.12996426 |
| 50 | MP0005310_abnormal_salivary_gland | 1.11836992 |
| 51 | MP0001851_eye_inflammation | 1.01145393 |
| 52 | MP0008057_abnormal_DNA_replication | 1.00997125 |
| 53 | MP0001348_abnormal_lacrimal_gland | 0.97311725 |
| 54 | MP0003045_fibrosis | 0.96652778 |
| 55 | MP0001533_abnormal_skeleton_physiology | 0.95122323 |
| 56 | MP0002998_abnormal_bone_remodeling | 0.92554968 |
| 57 | MP0002019_abnormal_tumor_incidence | 0.91251312 |
| 58 | MP0005023_abnormal_wound_healing | 0.84002952 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 0.83612431 |
| 60 | MP0005397_hematopoietic_system_phenotyp | 0.81097338 |
| 61 | MP0001545_abnormal_hematopoietic_system | 0.81097338 |
| 62 | MP0003693_abnormal_embryo_hatching | 0.76184779 |
| 63 | MP0005076_abnormal_cell_differentiation | 0.75041269 |
| 64 | MP0008961_abnormal_basal_metabolism | 0.71816820 |
| 65 | MP0002163_abnormal_gland_morphology | 0.70919832 |
| 66 | MP0000477_abnormal_intestine_morphology | 0.70022601 |
| 67 | MP0000604_amyloidosis | 0.70017332 |
| 68 | MP0009763_increased_sensitivity_to | 0.67038564 |
| 69 | MP0005075_abnormal_melanosome_morpholog | 0.66538747 |
| 70 | MP0000609_abnormal_liver_physiology | 0.65784786 |
| 71 | MP0010352_gastrointestinal_tract_polyps | 0.65541295 |
| 72 | MP0003795_abnormal_bone_structure | 0.65430118 |
| 73 | MP0002822_catalepsy | 0.61218108 |
| 74 | MP0003077_abnormal_cell_cycle | 0.61003189 |
| 75 | MP0001191_abnormal_skin_condition | 0.59347746 |
| 76 | MP0001243_abnormal_dermal_layer | 0.51619887 |
| 77 | MP0008569_lethality_at_weaning | 0.51141318 |
| 78 | MP0001663_abnormal_digestive_system | 0.50990639 |
| 79 | MP0010094_abnormal_chromosome_stability | 0.50700487 |
| 80 | MP0010234_abnormal_vibrissa_follicle | 0.50169172 |
| 81 | MP0001216_abnormal_epidermal_layer | 0.49565911 |
| 82 | MP0004742_abnormal_vestibular_system | 0.49489774 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.48682114 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 0.45754864 |
| 85 | MP0002136_abnormal_kidney_physiology | 0.45727747 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.44608967 |
| 87 | MP0004185_abnormal_adipocyte_glucose | 0.41574391 |
| 88 | MP0002132_abnormal_respiratory_system | 0.39365716 |
| 89 | MP0000367_abnormal_coat/_hair | 0.38725220 |
| 90 | MP0000313_abnormal_cell_death | 0.37877399 |
| 91 | MP0003787_abnormal_imprinting | 0.37703174 |
| 92 | MP0008873_increased_physiological_sensi | 0.36962548 |
| 93 | MP0002083_premature_death | 0.36537978 |
| 94 | MP0005451_abnormal_body_composition | 0.36207794 |
| 95 | MP0000598_abnormal_liver_morphology | 0.35675300 |
| 96 | MP0003959_abnormal_lean_body | 0.35620810 |
| 97 | MP0004957_abnormal_blastocyst_morpholog | 0.35516717 |
| 98 | MP0003111_abnormal_nucleus_morphology | 0.34006013 |
| 99 | MP0001881_abnormal_mammary_gland | 0.33987259 |
| 100 | MP0009764_decreased_sensitivity_to | 0.32893555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of T cell number (HP:0011839) | 7.86660208 |
| 2 | T lymphocytopenia (HP:0005403) | 7.81244116 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 7.00391576 |
| 4 | Stomatitis (HP:0010280) | 5.91494666 |
| 5 | Severe combined immunodeficiency (HP:0004430) | 5.74664312 |
| 6 | Abnormality of T cells (HP:0002843) | 5.56957597 |
| 7 | Combined immunodeficiency (HP:0005387) | 5.41278706 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 4.80034288 |
| 9 | IgG deficiency (HP:0004315) | 4.65535192 |
| 10 | Abnormality of B cell number (HP:0010975) | 4.65468927 |
| 11 | B lymphocytopenia (HP:0010976) | 4.65468927 |
| 12 | Increased IgM level (HP:0003496) | 4.50626505 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 4.47626872 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.44204160 |
| 15 | Lymphopenia (HP:0001888) | 4.37839313 |
| 16 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 4.36534057 |
| 17 | Recurrent bronchitis (HP:0002837) | 4.31256689 |
| 18 | Recurrent viral infections (HP:0004429) | 4.25251392 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.93324281 |
| 20 | IgM deficiency (HP:0002850) | 3.92492162 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.85866308 |
| 22 | Recurrent cutaneous fungal infections (HP:0011370) | 3.85866308 |
| 23 | Eosinophilia (HP:0001880) | 3.83166662 |
| 24 | Abnormality of eosinophils (HP:0001879) | 3.78683648 |
| 25 | Eczematoid dermatitis (HP:0000976) | 3.77414714 |
| 26 | Leukocytosis (HP:0001974) | 3.73085871 |
| 27 | Abnormality of T cell physiology (HP:0011840) | 3.72751830 |
| 28 | Abnormality of the fingertips (HP:0001211) | 3.68283093 |
| 29 | Joint swelling (HP:0001386) | 3.61967183 |
| 30 | Basal cell carcinoma (HP:0002671) | 3.54813562 |
| 31 | Myositis (HP:0100614) | 3.54551795 |
| 32 | Chronic otitis media (HP:0000389) | 3.52660050 |
| 33 | Chronic diarrhea (HP:0002028) | 3.50763798 |
| 34 | Pustule (HP:0200039) | 3.42123522 |
| 35 | Autoimmune thrombocytopenia (HP:0001973) | 3.32998907 |
| 36 | Nasal polyposis (HP:0100582) | 3.26653256 |
| 37 | Granulocytopenia (HP:0001913) | 3.24125335 |
| 38 | Thrombocytosis (HP:0001894) | 3.16474835 |
| 39 | Thyroiditis (HP:0100646) | 2.92322000 |
| 40 | Abnormality of DNA repair (HP:0003254) | 2.90702989 |
| 41 | Hypergammaglobulinemia (HP:0010702) | 2.90326011 |
| 42 | Recurrent abscess formation (HP:0002722) | 2.89528413 |
| 43 | Recurrent otitis media (HP:0000403) | 2.83370625 |
| 44 | IgA deficiency (HP:0002720) | 2.81971370 |
| 45 | Abnormality of the nasal mucosa (HP:0000433) | 2.74350083 |
| 46 | Poikiloderma (HP:0001029) | 2.70159982 |
| 47 | Entropion (HP:0000621) | 2.69210229 |
| 48 | Hemoptysis (HP:0002105) | 2.69051276 |
| 49 | Hypoplasia of the thymus (HP:0000778) | 2.64315843 |
| 50 | Lymphoma (HP:0002665) | 2.62739391 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.60248549 |
| 52 | Vasculitis (HP:0002633) | 2.59042151 |
| 53 | Chronic obstructive pulmonary disease (HP:0006510) | 2.51887230 |
| 54 | Obstructive lung disease (HP:0006536) | 2.51887230 |
| 55 | Gastrointestinal inflammation (HP:0004386) | 2.45388259 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 2.41858272 |
| 57 | Optic neuritis (HP:0100653) | 2.41858272 |
| 58 | Petechiae (HP:0000967) | 2.41591269 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.38894610 |
| 60 | Cheilitis (HP:0100825) | 2.36822502 |
| 61 | Meningitis (HP:0001287) | 2.34833606 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.32936480 |
| 63 | Periodontitis (HP:0000704) | 2.31732467 |
| 64 | Bronchitis (HP:0012387) | 2.31682253 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 2.31412952 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.27171700 |
| 67 | Recurrent skin infections (HP:0001581) | 2.13732907 |
| 68 | Encephalitis (HP:0002383) | 2.13404592 |
| 69 | Abnormal platelet volume (HP:0011876) | 2.13133049 |
| 70 | Hypochromic anemia (HP:0001931) | 2.10207635 |
| 71 | Hypoproteinemia (HP:0003075) | 2.06891240 |
| 72 | Mediastinal lymphadenopathy (HP:0100721) | 2.02931110 |
| 73 | Increased IgE level (HP:0003212) | 2.01603061 |
| 74 | Orchitis (HP:0100796) | 2.01022012 |
| 75 | Colitis (HP:0002583) | 2.00403572 |
| 76 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.98576112 |
| 77 | Increased density of long bones (HP:0006392) | 1.98094888 |
| 78 | Epistaxis (HP:0000421) | 1.96615207 |
| 79 | Gingivitis (HP:0000230) | 1.94746324 |
| 80 | Chest pain (HP:0100749) | 1.94730514 |
| 81 | Prolonged bleeding time (HP:0003010) | 1.92193031 |
| 82 | Arterial thrombosis (HP:0004420) | 1.89439124 |
| 83 | Amaurosis fugax (HP:0100576) | 1.89257895 |
| 84 | Hepatitis (HP:0012115) | 1.86193270 |
| 85 | Keratoconjunctivitis sicca (HP:0001097) | 1.85133634 |
| 86 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82294755 |
| 87 | Pulmonary embolism (HP:0002204) | 1.81182872 |
| 88 | Prominent nose (HP:0000448) | 1.81017491 |
| 89 | Ureteral stenosis (HP:0000071) | 1.80262828 |
| 90 | Abnormality of the endocardium (HP:0004306) | 1.79844849 |
| 91 | Reticulocytopenia (HP:0001896) | 1.78798286 |
| 92 | Abnormality of the prostate (HP:0008775) | 1.74757950 |
| 93 | Chronic sinusitis (HP:0011109) | 1.74639304 |
| 94 | Purpura (HP:0000979) | 1.73409454 |
| 95 | Bronchiectasis (HP:0002110) | 1.73250077 |
| 96 | Abnormal number of incisors (HP:0011064) | 1.72428791 |
| 97 | Agammaglobulinemia (HP:0004432) | 1.71883574 |
| 98 | Microcytic anemia (HP:0001935) | 1.71626142 |
| 99 | Frequent falls (HP:0002359) | 1.71302066 |
| 100 | Verrucae (HP:0200043) | 1.70614517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.17287355 |
| 2 | MAP4K1 | 5.55413728 |
| 3 | IKBKE | 3.93509846 |
| 4 | FGFR4 | 3.92959092 |
| 5 | ITK | 3.22304683 |
| 6 | ZAP70 | 3.19567408 |
| 7 | JAK3 | 3.14643396 |
| 8 | TYK2 | 3.04715442 |
| 9 | TBK1 | 2.69409239 |
| 10 | FGFR3 | 2.32440767 |
| 11 | MAP3K14 | 2.27006563 |
| 12 | JAK1 | 2.26645875 |
| 13 | STK10 | 2.21952558 |
| 14 | LCK | 2.11130341 |
| 15 | TEC | 1.90052552 |
| 16 | MAP3K13 | 1.75777573 |
| 17 | NLK | 1.62964596 |
| 18 | PRKCH | 1.62705327 |
| 19 | GRK6 | 1.58140055 |
| 20 | PKN2 | 1.56953208 |
| 21 | TAOK1 | 1.55258553 |
| 22 | HCK | 1.53396922 |
| 23 | EEF2K | 1.52762473 |
| 24 | MST4 | 1.42518350 |
| 25 | SYK | 1.34409117 |
| 26 | CSK | 1.29777239 |
| 27 | KIT | 1.25096538 |
| 28 | PRKCQ | 1.23175580 |
| 29 | BTK | 1.16212280 |
| 30 | IKBKB | 1.09821879 |
| 31 | KDR | 1.05269845 |
| 32 | LRRK2 | 1.02841211 |
| 33 | PASK | 0.99520725 |
| 34 | JAK2 | 0.99472869 |
| 35 | MAP3K11 | 0.99239050 |
| 36 | NME2 | 0.98873433 |
| 37 | MAP3K7 | 0.95435337 |
| 38 | MAP2K3 | 0.90820614 |
| 39 | TAOK2 | 0.89025717 |
| 40 | MAP3K10 | 0.86088763 |
| 41 | TYRO3 | 0.81976145 |
| 42 | MAP3K12 | 0.81968727 |
| 43 | TNIK | 0.81304772 |
| 44 | CHUK | 0.79740983 |
| 45 | TLK1 | 0.73572851 |
| 46 | FGFR1 | 0.71472688 |
| 47 | TRIB3 | 0.70499690 |
| 48 | MARK3 | 0.68007714 |
| 49 | FES | 0.65536842 |
| 50 | TGFBR1 | 0.64540259 |
| 51 | CDK12 | 0.64092749 |
| 52 | LYN | 0.62979729 |
| 53 | FGFR2 | 0.62091235 |
| 54 | PDGFRB | 0.59878395 |
| 55 | SIK2 | 0.59774639 |
| 56 | PDK1 | 0.58330554 |
| 57 | RPS6KA4 | 0.56777525 |
| 58 | PIM1 | 0.55282804 |
| 59 | TNK2 | 0.54086794 |
| 60 | MAPK11 | 0.53958063 |
| 61 | CLK1 | 0.53088525 |
| 62 | MAP3K3 | 0.52102444 |
| 63 | INSR | 0.50770299 |
| 64 | CDK9 | 0.49084157 |
| 65 | FLT3 | 0.49077429 |
| 66 | FYN | 0.47456099 |
| 67 | NTRK2 | 0.46655026 |
| 68 | IGF1R | 0.44641830 |
| 69 | ALK | 0.42895861 |
| 70 | MARK2 | 0.42398467 |
| 71 | MAP3K8 | 0.40541777 |
| 72 | TGFBR2 | 0.40009790 |
| 73 | BLK | 0.39616675 |
| 74 | ACVR1B | 0.38181083 |
| 75 | EPHB1 | 0.36370745 |
| 76 | PTK6 | 0.36324012 |
| 77 | MAP2K6 | 0.33881261 |
| 78 | HIPK2 | 0.33497840 |
| 79 | TESK2 | 0.33321244 |
| 80 | CSF1R | 0.32294910 |
| 81 | MELK | 0.31513837 |
| 82 | EGFR | 0.31185145 |
| 83 | RPS6KA5 | 0.30640116 |
| 84 | CDK4 | 0.30033114 |
| 85 | DMPK | 0.29619666 |
| 86 | MAPK7 | 0.28485353 |
| 87 | ROCK2 | 0.28011609 |
| 88 | TTN | 0.27003408 |
| 89 | MAPK3 | 0.26122458 |
| 90 | DYRK1B | 0.23499069 |
| 91 | MAPK12 | 0.19474551 |
| 92 | CDK6 | 0.18916085 |
| 93 | BRD4 | 0.17775653 |
| 94 | PIM2 | 0.16880018 |
| 95 | SRC | 0.16619713 |
| 96 | EPHA3 | 0.16574487 |
| 97 | PRKD2 | 0.16382235 |
| 98 | RET | 0.16054877 |
| 99 | ABL1 | 0.15504806 |
| 100 | ATR | 0.15494002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.44951537 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.59798787 |
| 3 | Measles_Homo sapiens_hsa05162 | 3.33095312 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.85677167 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.84778187 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.84153716 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.70944182 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.61837618 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.56192105 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.30116962 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.25668659 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.24256253 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.23609936 |
| 14 | Viral myocarditis_Homo sapiens_hsa05416 | 2.12869495 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.87800481 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.81725821 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.76333639 |
| 18 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.68258352 |
| 19 | Hepatitis B_Homo sapiens_hsa05161 | 1.63244747 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.62854003 |
| 21 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.61218215 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59448508 |
| 23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54021014 |
| 24 | Ribosome_Homo sapiens_hsa03010 | 1.46364075 |
| 25 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45902818 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40267137 |
| 27 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.33688399 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29717715 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29239743 |
| 30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28938308 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25007052 |
| 32 | HTLV-I infection_Homo sapiens_hsa05166 | 1.24587959 |
| 33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23922560 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.17579458 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.16613585 |
| 36 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13544991 |
| 37 | Asthma_Homo sapiens_hsa05310 | 1.10390116 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.04405918 |
| 39 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95004669 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94207188 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 0.93142468 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92100224 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90475187 |
| 44 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90150326 |
| 45 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88314446 |
| 46 | Spliceosome_Homo sapiens_hsa03040 | 0.84860674 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82530906 |
| 48 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81991602 |
| 49 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79916514 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 0.79556613 |
| 51 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76374370 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76056218 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.74066554 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 0.72244472 |
| 55 | Malaria_Homo sapiens_hsa05144 | 0.69149625 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68820987 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66294445 |
| 58 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.63587630 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59703749 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.57789540 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.52239291 |
| 62 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51464083 |
| 63 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.49514353 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.43719443 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42911007 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.40711095 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.38701903 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.36974246 |
| 69 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36618629 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36572141 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.36476544 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.36435824 |
| 73 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36380509 |
| 74 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35141395 |
| 75 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35118217 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34251084 |
| 77 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.34225014 |
| 78 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.33616353 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.32059447 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30771007 |
| 81 | DNA replication_Homo sapiens_hsa03030 | 0.29729594 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27802811 |
| 83 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26086065 |
| 84 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25122615 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.23835609 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.23193760 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22321832 |
| 88 | RNA transport_Homo sapiens_hsa03013 | 0.22237023 |
| 89 | Lysine degradation_Homo sapiens_hsa00310 | 0.21293973 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20993642 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20805516 |
| 92 | Pathways in cancer_Homo sapiens_hsa05200 | 0.19100202 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.18386612 |
| 94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.15370498 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.14960065 |
| 96 | Mismatch repair_Homo sapiens_hsa03430 | 0.14104982 |
| 97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.14092384 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.13583130 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.10041145 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.09843884 |

